BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 31951638)

  • 21. ARID5B, CEBPE and PIP4K2A Germline Genetic Polymorphisms and Risk of Childhood Acute Lymphoblastic Leukemia in Mexican Patients: A MIGICCL Study.
    Bekker-Méndez VC; Núñez-Enríquez JC; Torres Escalante JL; Alvarez-Olmos E; González-Montalvoc PM; Jiménez-Hernández E; Sansón AM; Leal YA; Ramos-Cervantes MT; Guerra-Castillo FX; Ortiz-Maganda MP; Flores-Lujano J; Pérez-Saldivar ML; Velazquez-Aviña MM; Bolea-Murga V; Torres-Nava JR; Amador-Sanchez R; Solis-Labastida KA; Rámirez-Bello J; Fragoso JM; Mejía-Aranguré JM;
    Arch Med Res; 2016 Nov; 47(8):623-628. PubMed ID: 28476190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenotype and Function of Activated Natural Killer Cells From Patients With Prostate Cancer: Patient-Dependent Responses to Priming and IL-2 Activation.
    Hood SP; Foulds GA; Imrie H; Reeder S; McArdle SEB; Khan M; Pockley AG
    Front Immunol; 2018; 9():3169. PubMed ID: 30761160
    [No Abstract]   [Full Text] [Related]  

  • 23. Defective NK cell activation in X-linked lymphoproliferative disease.
    Benoit L; Wang X; Pabst HF; Dutz J; Tan R
    J Immunol; 2000 Oct; 165(7):3549-53. PubMed ID: 11034354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and Characterization of Novel Fusion Genes with Potential Clinical Applications in Mexican Children with Acute Lymphoblastic Leukemia.
    Mata-Rocha M; Rangel-López A; Jiménez-Hernández E; Morales-Castillo BA; González-Torres C; Gaytan-Cervantes J; Álvarez-Olmos E; Núñez-Enríquez JC; Fajardo-Gutiérrez A; Martín-Trejo JA; Solís-Labastida KA; Medina-Sansón A; Flores-Lujano J; Sepúlveda-Robles OA; Peñaloza-González JG; Espinoza-Hernández LE; Núñez-Villegas NN; Espinosa-Elizondo RM; Cortés-Herrera B; Torres-Nava JR; Flores-Villegas LV; Merino-Pasaye LE; Bekker-Méndez VC; Velázquez-Aviña MM; Pérez-Saldívar ML; Bautista-Martínez BA; Amador-Sánchez R; González-Avila AI; Jiménez-Morales S; Duarte-Rodríguez DA; Santillán-Juárez JD; García-Velázquez AJ; Rosas-Vargas H; Mejía-Aranguré JM
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31096545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural killer cells from patients with chronic rhinosinusitis have impaired effector functions.
    Kim JH; Kim GE; Cho GS; Kwon HJ; Joo CH; Kim HS; Jang YJ
    PLoS One; 2013; 8(10):e77177. PubMed ID: 24204766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Childhood acute leukemias are frequent in Mexico City: descriptive epidemiology.
    Pérez-Saldivar ML; Fajardo-Gutiérrez A; Bernáldez-Ríos R; Martínez-Avalos A; Medina-Sanson A; Espinosa-Hernández L; Flores-Chapa Jde D; Amador-Sánchez R; Peñaloza-González JG; Alvarez-Rodríguez FJ; Bolea-Murga V; Flores-Lujano J; Rodríguez-Zepeda Mdel C; Rivera-Luna R; Dorantes-Acosta EM; Jiménez-Hernández E; Alvarado-Ibarra M; Velázquez-Aviña MM; Torres-Nava JR; Duarte-Rodríguez DA; Paredes-Aguilera R; Del Campo-Martínez Mde L; Cárdenas-Cardos R; Alamilla-Galicia PH; Bekker-Méndez VC; Ortega-Alvarez MC; Mejia-Arangure JM
    BMC Cancer; 2011 Aug; 11():355. PubMed ID: 21846410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and prognostic significance of murine double minute protein-2 overexpression and P53 gene mutations in childhood acute lymphoblastic leukemia.
    Hendy OM; Elghannam DM; El-Sharnouby JA; Goda EF; El-Ashry R; Al-Tonbary Y
    Egypt J Immunol; 2008; 15(1):93-100. PubMed ID: 20306673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targets.
    Penack O; Gentilini C; Fischer L; Asemissen AM; Scheibenbogen C; Thiel E; Uharek L
    Leukemia; 2005 May; 19(5):835-40. PubMed ID: 15744340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
    Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
    J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impairment in cytotoxicity and expression of NK cell- activating receptors on human NK cells following exposure to asbestos fibers.
    Nishimura Y; Miura Y; Maeda M; Kumagai N; Murakami S; Hayashi H; Fukuoka K; Nakano T; Otsuki T
    Int J Immunopathol Pharmacol; 2009; 22(3):579-90. PubMed ID: 19822075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of natural killer cells expressing markers associated with maturity and cytotoxicity in children and young adults with sickle cell disease.
    Abraham AA; Lang H; Meier ER; Nickel RS; Dean M; Lawal N; Speller-Brown B; Wang Y; Kean L; Bollard CM
    Pediatr Blood Cancer; 2019 May; 66(5):e27601. PubMed ID: 30609269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of gene rearrangements in Mexican children with acute lymphoblastic leukemia: a population study-report from the Mexican Interinstitutional Group for the identification of the causes of childhood leukemia.
    Bekker-Méndez VC; Miranda-Peralta E; Núñez-Enríquez JC; Olarte-Carrillo I; Guerra-Castillo FX; Pompa-Mera EN; Ocaña-Mondragón A; Rangel-López A; Bernáldez-Ríos R; Medina-Sanson A; Jiménez-Hernández E; Amador-Sánchez R; Peñaloza-González JG; de Diego Flores-Chapa J; Fajardo-Gutiérrez A; Flores-Lujano J; Rodríguez-Zepeda Mdel C; Dorantes-Acosta EM; Bolea-Murga V; Núñez-Villegas N; Velázquez-Aviña MM; Torres-Nava JR; Reyes-Zepeda NC; González-Bonilla C; Mejía-Aranguré JM
    Biomed Res Int; 2014; 2014():210560. PubMed ID: 25692130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Screening for cytotoxic defects with flow cytometric detection of CD107α on natural killer cells and cytotoxic lymphocyte cells].
    Wang J; Liu Z; Jiang LP; An YF; Zhao XD
    Zhonghua Er Ke Za Zhi; 2012 May; 50(5):386-91. PubMed ID: 22883044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of NK cell-mediated cytotoxicity by a SAP-independent receptor of the CD2 family.
    Bouchon A; Cella M; Grierson HL; Cohen JI; Colonna M
    J Immunol; 2001 Nov; 167(10):5517-21. PubMed ID: 11698418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced release and binding of perforin at the immunological synapse underlies the age-related decline in natural killer cell cytotoxicity.
    Hazeldine J; Hampson P; Lord JM
    Aging Cell; 2012 Oct; 11(5):751-9. PubMed ID: 22642232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defect of NK activity in children with untreated acute lymphocytic leukemia (ALL). I. Dependence on the blast count and phenotype, and response to exogenous and endogenous alpha-interferon.
    Gabrilovac J; Rajić L; Martin-Kleiner I; Osmak M; Batinić D; Tiefenbach A; Boranić M
    J Clin Lab Immunol; 1989 May; 29(1):9-15. PubMed ID: 2628585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hcmv-miR-UL112 attenuates NK cell activity by inhibition type I interferon secretion.
    Huang Y; Chen D; He J; Cai J; Shen K; Liu X; Yang X; Xu L
    Immunol Lett; 2015 Feb; 163(2):151-6. PubMed ID: 25530545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased natural killer cell activity and numbers of Leu-7 and Leu-11b (CD 16)-positive cells in bone marrow of children in remission from acute lymphoblastic leukaemia.
    Sørskaar D; Førre O; Lie SO
    Scand J Immunol; 1989 Jan; 29(1):65-72. PubMed ID: 2466327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of Frequencies, Compositions, and/or Antileukemic Activity of (DC-stimulated) Invariant NKT, NK and CIK Cells on the Outcome of Patients With AML, ALL and CLL.
    Boeck CL; Amberger DC; Doraneh-Gard F; Sutanto W; Guenther T; Schmohl J; Schuster F; Salih H; Babor F; Borkhardt A; Schmetzer H
    J Immunother; 2017; 40(6):224-248. PubMed ID: 28557814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progressive Impairment of NK Cell Cytotoxic Degranulation Is Associated With TGF-β1 Deregulation and Disease Progression in Pancreatic Cancer.
    Jun E; Song AY; Choi JW; Lee HH; Kim MY; Ko DH; Kang HJ; Kim SW; Bryceson Y; Kim SC; Kim HS
    Front Immunol; 2019; 10():1354. PubMed ID: 31281312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.